Floatz logo

ip-001

Hepatocellular Carcinoma

Robert C. MartinPhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

262 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB
Eloxatin
Li Qiang
Phase 4BB
Calcium folinate pentahydrate
Li Qiang
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB

View all 50 →

Same molecule, other indications

ip-001 is also rated in:

metastasis from malignant tumor of colonDormant
BB
Indicative ·
64 / 100
View asset →
Colon Cancer Liver MetastasesDormant
B
Indicative ·
57 / 100
View asset →
rectal cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →